跳至主要内容
临床试验/NCT01099865
NCT01099865已完成不适用

High-sensitivity C-reactive Protein and UKPDS Risk Score in Type 2 Diabetes: Nalysis With 18F-Fluorodeoxyglucose Positron Emission Tomography

Korea University1 个研究点 分布在 1 个国家目标入组 56 人开始时间: 2009年12月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
56
试验地点
1

研究概览

简要总结

The UKPDS risk score is recommended to assess global risk for future coronary heart disease (CHD) events in primary prevention. Recently, high-sensitivity C-reactive protein (hsCRP) has emerged as a strong independent risk factor for CHD. 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) is a promising imaging technique for the evaluation of vascular inflammation that reflects vulnerable atherosclerotic plaque.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
16 Years 至 80 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Type 2 diabetes

排除标准

  • Myocardial infarction, unstable angina, stroke, peripheral artery disease, or cardiovascular revascularization
  • Resting blood pressure ≥160/100 mmHg
  • Malignancy, or severe renal or hepatic disease
  • Participants were free of any lipid-lowering therapies and postmenopausal hormone replacement therapy at least the 6 month period prior to enrollment
  • History of inflammatory condition or those taking medications that might affect inflammatory status within 6 months

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验

High-sensitivity C-reactive Protein and United... | 临床试验